Objective To study the expression of HER2 in uroepithelium cell carcinoma of bladder,mucosa in the paracarcinoma and normal mucous of urinary bladder,and to explore its correlation with clinic factors,grade and stage of the bladder carcinoma and evaluate whether HER2 can serve as marker to decide the biological behavior of bladder carcinoma.

Methods:Primary porcine urothelial cells(UC) were obtained from the porcine bladder by enzymatic digestion and detected by immunofluorescence and RT-PCR.

Objectives:Using bladder acellular matrix graft (BAMG) as scaffold,urothelial cell (UC) and smooth muscle cell (SMC) as seeding cells,to form a sandwich structure of bladder wall in vitro.

Expression of KAI1 in urothelial cancer tissues and its relationship with invasion and metastasis of urothelial cancer;

To evaluate the clinical value of NMP22 for the diagnosis of urothelial cancer.

Telomerase activity in urine in diagnosis and recurrence surveillance of urothelial carcinoma;

Analysis of the clinicopathological characteristics of patients with upper tract urothelial carcinoma

BACKGROUND & OBJECTIVE: Urothelial carcinoma of the urinary bladder is a common malignant neoplasm of the genitourinary system.

Expressions of Survivin,p53 and bcl-2 in uroepithelium carcinoma and their clinical significance;

Objective: To investigate the expressions of Survivin、p53 and bcl-2 in uroepithelium carcinoma tissues, and their correlations with uroepithelium tumor malignancy.